Feed Preview


Hereditary Cancer Syndromes

Hereditary Cancer Syndromes diagram by SINITAR, Shutterstock
SINITAR, Shutterstock

Hereditary cancer syndromes comprise 5% of all cancers and have an increased risk of early onset and of multiple or bilateral malignancies. Here is the latest research on hereditary cancer syndromes.

Top 20 most recent papers
Cancer Letters

Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma

Cancer LettersJanuary 21, 2020
Tatevik R BroutianMaura L Gillison
Annals of Oncology : Official Journal of the European Society for Medical Oncology

Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors

Annals of Oncology : Official Journal of the European Society for Medical OncologyJanuary 22, 2020
E ProsM Sanchez-Cespedes
Journal for Immunotherapy of Cancer

Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models

Journal for Immunotherapy of CancerJanuary 22, 2020
Ling ZhangChristian S Hinrichs
Annals of Oncology : Official Journal of the European Society for Medical Oncology

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

Annals of Oncology : Official Journal of the European Society for Medical OncologyJanuary 22, 2020
J MazieresJ Y Blay
PLoS Computational Biology

Between-tumor and within-tumor heterogeneity in invasive potential

PLoS Computational BiologyJanuary 22, 2020
Veena PadmanabanJoel S Bader
Nucleic Acids Research

HSF2BP negatively regulates homologous recombination in DNA interstrand crosslink repair

Nucleic Acids ResearchJanuary 22, 2020
Koichi SatoAlex N Zelensky
The Journal of Clinical Investigation

TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination

The Journal of Clinical InvestigationJanuary 22, 2020
Benjamin C ChandlerCorey Speers
Nature Communications

Mutational signatures in tumours induced by high and low energy radiation in Trp53 deficient mice

Nature CommunicationsJanuary 22, 2020
Yun Rose LiAllan Balmain
Nature Communications

Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer

Nature CommunicationsJanuary 22, 2020
Ritika TiwariBushra Ateeq
Cell Death & Disease

NEDD4L downregulates autophagy and cell growth by modulating ULK1 and a glutamine transporter

Cell Death & DiseaseJanuary 22, 2020
Dong-Eun LeeHeesun Cheong
Journal of Molecular and Cellular Cardiology

Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53

Journal of Molecular and Cellular CardiologyJanuary 21, 2020
Mary E HaywoodMatthew R G Taylor

Deciphering the Signaling Network Landscape of Breast Cancer Improves Drug Sensitivity Prediction

bioRxivJanuary 21, 2020
Marco TognettiBernd Bodenmiller
Cell Cycle

The microtubule targeting agents eribulin and paclitaxel activate similar signaling pathways and induce cell death predominantly in a caspase-independent manner

Cell CycleJanuary 22, 2020
Lisa C HüsemannReiner U Jänicke
Journal of Cellular Physiology

Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function

Journal of Cellular PhysiologyJanuary 22, 2020
Nele Van Der SteenGodefridus J Peters
Life Science Alliance

Nup93 regulates breast tumor growth by modulating cell proliferation and actin cytoskeleton remodeling

Life Science AllianceJanuary 22, 2020
Simone BersiniMartin W Hetzer

sismonr: Simulation of In Silico Multi-Omic Networks with adjustable ploidy and post-transcriptional regulation in R

BioinformaticsJanuary 22, 2020
Olivia Angelin-BonnetMatthieu Vignes
Nature Biotechnology

Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring

Nature BiotechnologyJanuary 22, 2020
Maruan HijaziPedro R Cutillas
PloS One

Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage

PloS OneJanuary 22, 2020
Zhi LiSandra Pellegrini
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology

Genistein Represses HOTAIR/Chromatin Remodeling Pathways to Suppress Kidney Cancer

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and PharmacologyJanuary 22, 2020
Mitsuho Imai-SumidaSoichiro Yamamura

Genetic risk factors for spontaneous pneumothorax in Birt-Hogg-Dubé syndrome

ChestJanuary 21, 2020
Elke C SattlerOrtrud K Steinlein

See more papers from this feed

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Hamartoma Syndrome, Multiple

Multiple Hamartoma Syndrome, also known as Cowden disease, is a hereditary autosomal dominant condition associated with mutations in tumor suppressor PTEN. Here is the latest research.

Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

Hereditary Nonpolyposis Colorectal Neoplasms

Hereditary Nonpolyposis Colorectal Neoplasms are a type of inherited autosomal dominant colon cancer and is associated with mutations in mismatch repair genes. Discover the latest research on Hereditary Nonpolyposis Colorectal Neoplasms.

Li-Fraumeni Syndrome

Li-Fraumeni Syndrome is a rare autosomal dominant syndrome caused by mutations in the tumor suppressor TP53 and characterized by mesenchymal and epithelial neoplasms and several sites. Here is the latest research.

Multiple Endocrine Neoplasia

Multiple Endocrine Neoplasia is a group of inherited autosomal dominant cancers that occur in multiple hormone producing grandular organs. Discover the latest research on Multiple Endocrine Neoplasia here.


Neurofibromatosis is a genetic disorder that causes tumors to form in the central nervous system. While these tumors are typically benign, they can become malignant. Other complications of neurofibromatosis include hearing loss, learning impairment, vision loss, etc. Here is the latest research.

Neurofibromatosis 1

Neurofibromatosis 1 (NF1), also known as von Recklinghausen disease, is an autosomal dominant condition caused by mutations in the NF1 gene. Here is the latest research.

Neurofibromatosis 2

Neurofibromatosis 2 (NF2) is a severe autosomal dominant disorder characterized by the occurrence of bilateral vestibular schwannomas and other benign tumors of the nervous system. Here is the latest research.

Peutz-Jeghers Syndrome

Peutz–Jeghers syndrome (PJS) is an autosomal dominant genetic disorder characterized by benign gastrointestinal polyps and melanosis. Discover the latest research on PJS here.

© 2020 Meta ULC. All rights reserved